Long-term outcomes of patients with metastatic gastric cancer after initial S-1 monotherapy

被引：0
作者：
Ayumu Hosokawa
Toshiro Sugiyama
Atsushi Ohtsu
Toshihiko Doi
Santa Hattori
Takashi Kojima
Tomonori Yano
Keiko Minashi
Manabu Muto
Shigeaki Yoshida
机构：
[1] University of Toyama,Department of Internal Medicine, Faculty of Medicine
[2] National Cancer Center Hospital East,Division of Gastrointestinal Oncology and Digestive Endoscopy
来源：
Journal of Gastroenterology | 2007年 / 42卷
关键词：
gastric cancer; chemotherapy; S-1; clinical practice;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：533 / 538
页数：5
相关论文
共 50 条
  • [21] Short-Term and Long-Term Outcomes After Gastrectomy for Gastric Cancer in Patients With Chronic Kidney Disease
    Sohei Matsumoto
    Tomoyoshi Takayama
    Kohei Wakatsuki
    Tetsuya Tanaka
    Kazuhiro Migita
    Yoshiyuki Nakajima
    World Journal of Surgery, 2014, 38 : 1453 - 1460
  • [22] Long-Term Survival in Patients With Metastatic Gastric and Gastroesophageal Cancer Treated With Surgery
    Badgwell, Brian
    Roy-Chowdhuri, Sinchita
    Chiang, Yi-Ju
    Matamoros, Aurelio
    Blum, Mariela
    Fournier, Keith
    Mansfield, Paul
    Ajani, Jaffer
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (07) : 875 - 881
  • [23] Pharmacokinetics of S-1 in patients with peritoneal dissemination of gastric cancer
    Oshima, Takashi
    Yamada, Roppei
    Hatori, Shinsuke
    Kunisaki, Chikara
    Imada, Toshio
    ONCOLOGY REPORTS, 2006, 16 (02) : 361 - 366
  • [24] Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002)
    Takahari, Daisuke
    Ito, Seiji
    Mizusawa, Junki
    Katayama, Hiroshi
    Terashima, Masanori
    Sasako, Mitsuru
    Morita, Shinji
    Nomura, Takashi
    Yamada, Makoto
    Fujiwara, Yoshiyuki
    Kimura, Yutaka
    Ikeda, Atsuki
    Kadokawa, Yoshio
    Sano, Takeshi
    GASTRIC CANCER, 2020, 23 (02) : 293 - 299
  • [25] Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002)
    Daisuke Takahari
    Seiji Ito
    Junki Mizusawa
    Hiroshi Katayama
    Masanori Terashima
    Mitsuru Sasako
    Shinji Morita
    Takashi Nomura
    Makoto Yamada
    Yoshiyuki Fujiwara
    Yutaka Kimura
    Atsuki Ikeda
    Yoshio Kadokawa
    Takeshi Sano
    Gastric Cancer, 2020, 23 : 293 - 299
  • [26] Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer
    Jeung, Hei Cheul
    Rha, Sun Young
    Park, Chan Hee
    Im, Chong-Kun
    Shin, Sang Joon
    Ahn, Joong Bae
    Noh, Sung Hoon
    Roh, Jae Kyung
    Chung, Hyun Cheol
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (03) : 787 - 796
  • [27] Long-term clinical remission in a patient with metastatic gastric cancer after palliative chemotherapy
    Teufel, A
    Lehnert, T
    Stremmel, W
    Rudi, J
    ONKOLOGIE, 2000, 23 (05): : 464 - 466
  • [28] Long-Term Safety Data on S-1 Administered After Previous Intolerance to Capecitabine-Containing Systemic Treatment for Metastatic Colorectal Cancer
    Punt, Cornelis J. A.
    Kwakman, Johannes J. M.
    Mol, Linda
    CLINICAL COLORECTAL CANCER, 2022, 21 (03) : 229 - 235
  • [29] S-1 Monotherapy in Patients with Advanced Biliary Tract Cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Yashima, Yoko
    Yagioka, Hiroshi
    Kogure, Hirofumi
    Arizumi, Toshihiko
    Togawa, Osamu
    Matsubara, Saburo
    Ito, Yukiko
    Nakai, Yousuke
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Tada, Minoru
    Kawabe, Takao
    Omata, Masao
    ONCOLOGY, 2009, 77 (01) : 71 - 74
  • [30] Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer
    Kong, Sun-Young
    Lim, Hyeong-Seok
    Nam, Byung-Ho
    Kook, Myeong-Cherl
    Kim, Young-Woo
    Ryu, Keun Won
    Lee, Jun Ho
    Choi, Il Ju
    Lee, Jin Soo
    Park, Young-lee
    Kim, Noe Kyeong
    Park, Sook Ryun
    PHARMACOGENOMICS, 2009, 10 (07) : 1147 - 1155
12345